Emerging Secondary Cancers to Kaposi Sarcoma

Submitted by admin5 on Fri, 10/27/2017 - 04:10

In the highly active antiretroviral therapy era, which secondary malignancy to Kaposi sarcoma has emerged as a new risk for patients?


A. Chronic myeloid leukemia

B. Chronic lymphocytic leukemia

C. Acute lymphocytic leukemia

D. Diffuse large B-cell lymphoma


To see the correct answer, click here.


Related Content

External Beam Radiotherapy Effective for Skin Kaposi Sarcoma Treatment

Improved Survival from Neoadjuvant Chemotherapy for Soft-Tissue Sarcoma